Related references
Note: Only part of the references are listed.Granulomatosis With Polyangiitis (Wegener's) Impact of Maintenance Therapy Duration
Jason Springer et al.
MEDICINE (2014)
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
L. Guillevin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
E. M. Miloslavsky et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
Ulrich Specks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up
Lorraine Harper et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis
Michael Walsh et al.
ARTHRITIS AND RHEUMATISM (2012)
Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease
JulieAnne G. McGregor et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Controlled Trial
Thomas F. Hiemstra et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
Rachel B. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of Duration of Glucocorticoid Therapy on Relapse Rate in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Meta-Analysis
Michael Walsh et al.
ARTHRITIS CARE & RESEARCH (2010)
Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial
Kirsten de Groot et al.
ANNALS OF INTERNAL MEDICINE (2009)
Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis.
Christian Pagnoux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis
K de Groot et al.
ARTHRITIS AND RHEUMATISM (2005)
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
D Jayne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Update on the European Vasculitis Study Group trials
D Jayne
CURRENT OPINION IN RHEUMATOLOGY (2001)
Share Paper
